photo_2022-01-10_15-20-30

Vaccine Giants to Meet EMA over Trial Shots Targeting Omicron Europe’s drugs regulator will hold talks with four leading Covid-19 vaccine makers to discuss potential trials for new jabs against the fast-spreading omicron variant, the agency’s executive director said. (Bloomberg) Pfizer, Moderna, Johnson & Johnson and Novavax will sit down with the European Medicines Agency in the coming days, and will be joined by US regulators too in a virtual meeting. It's claimed variant-based vaccines can be rolled out within 3-4 months and the Omicron one could be ready by spring.